Atea Pharmaceuticals Inc (AVIR)
3.24
+0.08
(+2.53%)
USD |
NASDAQ |
Nov 21, 16:00
3.24
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Market Cap: 273.66M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 266.90M |
| November 19, 2024 | 265.21M |
| November 18, 2024 | 267.75M |
| November 15, 2024 | 271.97M |
| November 14, 2024 | 279.57M |
| November 13, 2024 | 282.95M |
| November 12, 2024 | 281.26M |
| November 11, 2024 | 283.80M |
| November 08, 2024 | 295.62M |
| November 07, 2024 | 290.55M |
| November 06, 2024 | 302.38M |
| November 05, 2024 | 283.80M |
| November 04, 2024 | 282.95M |
| November 01, 2024 | 277.88M |
| October 31, 2024 | 273.66M |
| October 30, 2024 | 277.04M |
| October 29, 2024 | 286.33M |
| October 28, 2024 | 288.86M |
| October 25, 2024 | 282.95M |
| October 24, 2024 | 285.49M |
| October 23, 2024 | 293.93M |
| October 22, 2024 | 300.69M |
| October 21, 2024 | 303.22M |
| October 18, 2024 | 322.65M |
| October 17, 2024 | 315.05M |
| Date | Value |
|---|---|
| October 16, 2024 | 318.43M |
| October 15, 2024 | 299.84M |
| October 14, 2024 | 298.15M |
| October 11, 2024 | 293.93M |
| October 10, 2024 | 282.11M |
| October 09, 2024 | 287.17M |
| October 08, 2024 | 288.02M |
| October 07, 2024 | 288.02M |
| October 04, 2024 | 292.24M |
| October 03, 2024 | 281.26M |
| October 02, 2024 | 284.64M |
| October 01, 2024 | 281.26M |
| September 30, 2024 | 282.95M |
| September 27, 2024 | 290.41M |
| September 26, 2024 | 290.41M |
| September 25, 2024 | 289.57M |
| September 24, 2024 | 295.48M |
| September 23, 2024 | 291.26M |
| September 20, 2024 | 309.83M |
| September 19, 2024 | 322.49M |
| September 18, 2024 | 336.84M |
| September 17, 2024 | 339.38M |
| September 16, 2024 | 328.40M |
| September 13, 2024 | 326.71M |
| September 12, 2024 | 309.83M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
233.62M
Minimum
Nov 22 2023
7.291B
Maximum
Feb 08 2021
1.098B
Average
431.01M
Median
Market Cap Benchmarks
| McKesson Corp | 79.75B |
| Pfizer Inc | 142.44B |
| Doximity Inc | 8.957B |
| Immuneering Corp | 65.52M |
| CEL-SCI Corp | 37.04M |
Market Cap Related Metrics
| PS Ratio | 0.7746 |
| Price to Book Value | 0.5968 |
| Price | 3.24 |
| Earnings Yield | -63.89% |
| Operating PE Ratio | 1.967 |
| Normalized PE Ratio | 2.382 |